Literature DB >> 8794380

Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2.

M J Grossel1, F Sverdrup, D E Breiding, E J Androphy.   

Abstract

Bovine papillomavirus type 1 replication was previously shown to require both the E1 initiator protein and the E2 transactivator protein. We show here that E1, in the absence of E2, is sufficient for low-level bovine papillomavirus type 1 DNA replication in C-33A cells. In addition, studies of genetically isolated E2 point mutants demonstrate that enhancement of replication by E2 does not require its transcriptional activation function. The uncoupling of the E2 functions suggests that stimulation of transcription and replication by enhancer proteins occurs via divergent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794380      PMCID: PMC190786     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Trans activation by the bovine papillomavirus E2 protein in Saccharomyces cerevisiae.

Authors:  L C Morrissey; J Barsoum; E J Androphy
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

2.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

3.  The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.

Authors:  E Ustav; M Ustav; P Szymanski; A Stenlund
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

4.  Nucleotides in the polyomavirus enhancer that control viral transcription and DNA replication.

Authors:  W J Tang; S L Berger; S J Triezenberg; W R Folk
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

5.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator.

Authors:  P F Lambert; B A Spalholz; P M Howley
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

6.  Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions.

Authors:  H Sakai; T Yasugi; J D Benson; J J Dowhanick; P M Howley
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Specific transcription factors stimulate simian virus 40 and polyomavirus origins of DNA replication.

Authors:  Z S Guo; M L DePamphilis
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

8.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains.

Authors:  I Giri; M Yaniv
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1.

Authors:  M Ustav; E Ustav; P Szymanski; A Stenlund
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  25 in total

1.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Levels of the E2 interacting protein TopBP1 modulate papillomavirus maintenance stage replication.

Authors:  Sriramana Kanginakudru; Marsha DeSmet; Yanique Thomas; Iain M Morgan; Elliot J Androphy
Journal:  Virology       Date:  2015-02-07       Impact factor: 3.616

3.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.

Authors:  E C Goodwin; L K Naeger; D E Breiding; E J Androphy; D DiMaio
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain.

Authors:  D E Breiding; F Sverdrup; M J Grossel; N Moscufo; W Boonchai; E J Androphy
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB.

Authors:  J M Yao; D E Breiding; E J Androphy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein.

Authors:  Peng-Sheng Zheng; Jane Brokaw; Alison A McBride
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1.

Authors:  David Gagnon; Hélène Sénéchal; Claudia M D'Abramo; Jennifer Alvarez; Alison A McBride; Jacques Archambault
Journal:  Virology       Date:  2013-03-11       Impact factor: 3.616

Review 9.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24

10.  Acetylation of conserved lysines in bovine papillomavirus E2 by p300.

Authors:  Edward J Quinlan; Sara P Culleton; Shwu-Yuan Wu; Cheng-Ming Chiang; Elliot J Androphy
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.